Ask Extension

What is Neotame?

The most recently-approved low-calorie sweetener, neotame was approved by the FDA in 2002 as a general purpose sweetener. Extensive review of over 100 scientific studies was completed prior to approval. Neotame has also been approved for use in multiple countries in Europe, Asia, North and South America, and Australia. Neotame is an artificial sweetener made by NutraSweet that is between 8,000 and 13,000 times sweeter than sucrose (table sugar). Neotame is not marketed under any brand names yet. It is partially absorbed, but rapidly metabolized and excreted, rendering it essentially calorie-free. Neotame is heat stable; thus, it can be used in cooking and baking.

Although it is related to aspartame, it doesn't carry the same warning about phenylalanine, because a minimal amount of phenylalanine is produced during digestion. Because of the extraordinary sweetening power of a small amount of neotame, the level of exposure to phenylalanine as it is released into the bloodstream is considered clinically insignificant. Therefore, products sweetened with neotame are not required to carry a statement on the label alerting persons with PKU to the presence of phenylalanine.

Additional Resources:

http://www.foodsafety.ksu.edu/en/faq-details.php?a=1&fc=38&id=7836




Article Details

Last Updated
19th of March, 2010

Would you like to...

Print this page Print this page

Email this page Email this page

Post a comment Post a comment

Subscribe me

Add to favorites Add to favorites

Remove Highlighting Remove Highlighting

Edit this Article

Quick Edit

Export to PDF

User Opinions (0 votes)

No users have voted.

How would you rate this answer?



Thank you for rating this answer.

Related Articles

No related articles were found.

Attachments

Visitor Comments

No visitor comments posted. Post a comment

Post a comment

To post a comment for this article, simply complete the form below. Fields marked with an asterisk are required.
   Name:
   Email:
* Comment:
* Enter the code below:
 

Continue